TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Alexion Pharma Nordics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
65,047
|
269,323
|
261,559 |
| Financial expenses |
264
|
1,798
|
40 |
| Earnings before taxes |
6,357
|
12,462
|
7,791 |
| EBITDA |
4,696
|
12,327
|
7,278 |
| Total assets |
94,921
|
176,522
|
107,642 |
| Current assets |
93,964
|
176,522
|
107,642 |
| Current liabilities |
65,937
|
121,893
|
61,723 |
| Equity capital |
28,984
|
54,629
|
45,919 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
30.5%
|
30.9%
|
42.7% |
| Turnover per employee |
4,065
|
19,237
|
17,437 |
| Profit as a percentage of turnover |
9.8%
|
4.6%
|
3.0% |
| Return on assets (ROA) |
7.0%
|
8.1%
|
7.3% |
| Current ratio |
142.5%
|
144.8%
|
174.4% |
| Return on equity (ROE) |
21.9%
|
22.8%
|
17.0% |
| Change turnover |
-204,276
|
7,764
|
27,393 |
| Change turnover % |
-76%
|
3%
|
12% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.